Sponsor pipeline

Artios Pharma Ltd clinical trial pipeline

Get alerts when Artios Pharma Ltd's trials change

2 active trials 2 recruiting 4 disease areas 4 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-07-31
Primary completion pushed: 2026-12 → 2028-01
Enrollment increased: 442 → 542 participants
Trial sites expanded: 79 → 82 locations
Completion pushed: 2027-12 → 2028-06
NCT04657068 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors · Phase 1/2

Active trials by phase

Phase 1/2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT04657068 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors Advanced Cancer Recruiting 2026-07-30
NCT05898399 Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA) Advanced Solid Tumor Recruiting 2026-05-01

Disease areas by active trials

Colorectal Cancer (1) · Pancreatic Cancer (1) · Ovarian Cancer (1) · Endometrial Cancer (1)

Get alerts when Artios Pharma Ltd's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free